Multiple intravenous transplantations of mesenchymal stem cells effectively restore long-term blood glucose homeostasis by hepatic engraftment and β-cell differentiation in streptozocin-induced diabetic mice
- PMID: 22004871
- DOI: 10.3727/096368911X603611
Multiple intravenous transplantations of mesenchymal stem cells effectively restore long-term blood glucose homeostasis by hepatic engraftment and β-cell differentiation in streptozocin-induced diabetic mice
Abstract
Depletion of pancreatic β-cells results in insulin insufficiency and diabetes mellitus (DM). Single transplantation of mesenchymal stem cells exhibits short-term effects in some preclinical studies. Here, we further investigated the long-term therapeutic effects of multiple intravenous MSC transplantations. In this study, multiple human MSC transplantations (4.2 × 10(7) cells/kg each time) were performed intravenously at 2-week intervals into streptozocin (STZ)-induced diabetic mice for 6 months. Blood sugar, insulin, renal function, cholesterol, and triglyceride levels were monitored. We demonstrated that compared to single intravenous transplantation, which only transiently decreased hyperglycemia, multiple MSC transplantations effectively restored blood glucose homeostasis. Systemic oxidative stress levels were reduced from the seventh week of treatment. From the 11th week, production of human insulin was markedly increased. When MSC transplantation was skipped after blood sugar level returned to normal at the end of 15th week, a sharp rebound of blood sugar occurred, and was then controlled by subsequent transplantations. At the end of 6 months, histopathology examination revealed MSCs specifically engrafted into liver tissues of the recipients. Fifty-one percent of human cells in the recipient liver coexpressed human insulin, especially those surrounding the central veins. Taken together, intravenous MSC delivery was safe and effective for blood glucose stabilization in this preclinical DM model. Multiple transplantations were essential to restore and maintain glucose homeostasis through decreasing systemic oxidative stress in the early stage and insulin production in the late stage. Liver engraftment and differentiation into insulin-producing cells account for the long-term therapeutic effects of MSCs.
Similar articles
-
Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes rats.Biochem Biophys Res Commun. 2013 Jul 5;436(3):418-23. doi: 10.1016/j.bbrc.2013.05.117. Epub 2013 Jun 11. Biochem Biophys Res Commun. 2013. PMID: 23770360
-
Transplantation of insulin-producing cells derived from umbilical cord stromal mesenchymal stem cells to treat NOD mice.Cell Transplant. 2011;20(3):455-66. doi: 10.3727/096368910X522270. Epub 2010 Aug 18. Cell Transplant. 2011. PMID: 20719086
-
Induction of insulin-producing cells derived from endometrial mesenchymal stem-like cells.J Pharmacol Exp Ther. 2010 Dec;335(3):817-29. doi: 10.1124/jpet.110.169284. Epub 2010 Sep 20. J Pharmacol Exp Ther. 2010. PMID: 20855446
-
Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes.Diabetes Metab. 2009 Apr;35(2):85-93. doi: 10.1016/j.diabet.2008.10.003. Epub 2009 Feb 20. Diabetes Metab. 2009. PMID: 19230736 Review.
-
Mesenchymal stem cells and type 1 diabetes treatment.Vnitr Lek. 2018 Fall;64(7-8):725-728. Vnitr Lek. 2018. PMID: 30441979 Review. English.
Cited by
-
Intrapancreatic autologous stem cell therapy for type 1 diabetes - an experimental study.Ann Med Surg (Lond). 2023 Jul 28;85(9):4355-4371. doi: 10.1097/MS9.0000000000000837. eCollection 2023 Sep. Ann Med Surg (Lond). 2023. PMID: 37663700 Free PMC article.
-
Stem cell transplantation therapy for diabetic foot ulcer: a narrative review.Asian Biomed (Res Rev News). 2021 Feb 21;15(1):3-18. doi: 10.2478/abm-2021-0002. eCollection 2021 Feb. Asian Biomed (Res Rev News). 2021. PMID: 37551298 Free PMC article. Review.
-
MitoTEMPOL modulates mitophagy and histopathology of Wistar rat liver after streptozotocin injection.Iran J Basic Med Sci. 2022 Nov;25(11):1382-1388. doi: 10.22038/IJBMS.2022.65285.14375. Iran J Basic Med Sci. 2022. PMID: 36474569 Free PMC article.
-
Stem cell therapy for type1 diabetes with transplantation of stem cells into the Omental pouch, peritoneum, and blood, experimental study.Ann Med Surg (Lond). 2022 Aug 27;81:104468. doi: 10.1016/j.amsu.2022.104468. eCollection 2022 Sep. Ann Med Surg (Lond). 2022. PMID: 36147094 Free PMC article.
-
Can mobilization of bone marrow stem cells be an alternative regenerative therapy to stem cell injection in a rat model of chronic kidney disease?Physiol Rep. 2022 Sep;10(17):e15448. doi: 10.14814/phy2.15448. Physiol Rep. 2022. PMID: 36065849 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
